Successful use of Filgotinib in the Treatment of Refractory Rheumatoid Arthritis-Associated Sweet Syndrome

Matteo Colina*; Alessia Barisani; Alberto Gualandi; Francesca Poli; Gabriele Campana

doi:10.37871/jbres2052

Letter

Successful use of Filgotinib in the Treatment of Refractory Rheumatoid Arthritis-Associated Sweet Syndrome

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

News & Press

Publish academic announcements

Share institutional updates, conference announcements, research highlights, and education/science initiatives on JBRES.

Free OptionsSponsored Banner

View Page Submit by Email

Publish Smarter

Quick reasons scholars choose us

Speed + clarity

Decision in 7–14 days

Double-blind review with actionable feedback and clear next steps.

Fast ReviewFair Process

Visibility

DOI + discovery support

Crossref DOI registration and discovery-focused publishing for global reach.

Crossref DOIDiscoverability

Author support

Responsive editorial help

Quick communication, formatting guidance, and proof support until publication.

SupportProof Help

Impact proof

Monthly reach updates

After publishing, we can share visibility signals (views, downloads, discoverability).

Reach ReportMetrics

Trust

Ethical, transparent publishing

Clear policies, COI handling, and publication ethics that protect your work.

EthicsTransparency

Ownership

You keep your rights

Open access publishing with author-friendly licensing and long-term availability.

Author RightsOpen Access

Quality polish

Editing + layout support

Cleaner formatting, better readability, and publication-ready presentation.

EditingProfessional Layout

Time saver

Clear submission guidance

Simple steps, helpful templates, and quick checks to reduce back-and-forth.

Easy SubmitLess Delay

Priority

Returning authors get faster handling

If you’ve published with us, we prioritize communication and processing.

PriorityReturning Authors

Visibility tools

Share-ready links and citations

DOI links, citation-ready details, and share options to amplify your paper.

Citation ReadyShare Tools

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access

Article Type Letter

Subject Medicine Group

OCLC JBRES Record

Matteo Colina*, Alessia Barisani, Alberto Gualandi, Francesca Poli and Gabriele Campana

Issue: Volume6-Issue1

Pages: 020-022

Received: 2024-12-30

Accepted: 2025-01-02

Published: 2025-01-06

Abstract

FullText HTML FullText PDF DOI: 10.37871/jbres2052

Certificate of Publication

Copyright

How to cite this article

Colina M, Barisani A, Gualandi A, Poli F, Campana G. Successful use of Filgotinib in the Treatment of Refractory Rheumatoid Arthritis-Associated Sweet Syndrome. J Biomed Res Environ Sci. 2025 Jan 06; 6(1): 020-022. doi: 10.37871/jbres2052, Article ID: JBRES2052, Available at: https://www.jelsciences.com/articles/ jbres2052.pdf

Subject area(s)

Rheumatology Dermatology

References

Namour F, Anderson K, Nelson C, Tasset C. Filgotinib: A Clinical Pharmacology Review. Clin Pharmacokinet. 2022 Jun;61(6):819-832. doi: 10.1007/s40262-022-01129-y. Epub 2022 May 31. PMID: 35637376; PMCID: PMC9249714.
Joshi TP, Friske SK, Hsiou DA, Duvic M. New Practical Aspects of Sweet Syndrome. Am J Clin Dermatol. 2022 May;23(3):301-318. doi: 10.1007/s40257-022-00673-4. Epub 2022 Feb 14. PMID: 35157247; PMCID: PMC8853033.
Smolen JS, LandewÃ© RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, MÃ¼ller-Ladner U, Mysler EF, da Silva JAP, PoÃ³r G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655. Epub 2020 Jan 22. PMID: 31969328.
Nousari Y, Wu BC, Valenzuela G. Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome. Clin Exp Dermatol. 2021 Oct;46(7):1330-1332. doi: 10.1111/ced.14712. Epub 2021 Jun 4. PMID: 33914946.
Lee YH, Song GG. Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in active rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs. Z Rheumatol. 2021 May;80(4):379-392. English. doi: 10.1007/s00393-020-00796-1. PMID: 32367211.